Rapamycin Clinical Trials

4 actively recruiting trials across 3 locations

No change since May 2026

Also known as: Rapamune, sirolimus, Sirolimus, RAPA

Pipeline

Phase 1: 2Phase 2: 1Phase 2/3: 1

Top Sponsors

Umoja Biopharma1
The University of Texas Health Science Center at San Antonio1
Nanjing IASO Biotechnology Co., Ltd.1
AgelessRx1

Indications

Cancer2
Geroscience1
Longevity1
GLP - 11
Alzheimer's Disease1

Other1 trial

UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies

Phase 1

Duarte, California1 trial

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

City of Hope

Phase 1

Chicago, Illinois1 trial

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

AgelessRx

Phase 2/3

San Antonio, Texas1 trial

Rapamycin - Effects on Alzheimer's and Cognitive Health

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.